Spruce Biosciences Statistics Share Statistics Spruce Biosciences has 563.05K
shares outstanding. The number of shares has increased by 2.61%
in one year.
Shares Outstanding 563.05K Shares Change (YoY) 2.61% Shares Change (QoQ) 2.56% Owned by Institutions (%) 4.78% Shares Floating 333.32K Failed to Deliver (FTD) Shares 46,698 FTD / Avg. Volume 605.13%
Short Selling Information The latest short interest is 618, so 0.11% of the outstanding
shares have been sold short.
Short Interest 618 Short % of Shares Out 0.11% Short % of Float 0.11% Short Ratio (days to cover) 1
Valuation Ratios PE Ratio 0 Forward PE -0.76 PS Ratio 0.04 Forward PS n/a PB Ratio 0.01 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Spruce Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.9,
with a Debt / Equity ratio of 0.1.
Current Ratio 2.9 Quick Ratio 2.9 Debt / Equity 0.1 Debt / EBITDA -0.05 Debt / FCF -0.05 Interest Coverage -182.9
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $245.55K Profits Per Employee $-2.65M Employee Count 20 Asset Turnover 0.11 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 1834.89% in the
last 52 weeks. The beta is 2.48, so Spruce Biosciences's
price volatility has been higher than the market average.
Beta 2.48 52-Week Price Change 1834.89% 50-Day Moving Average 7.66 200-Day Moving Average 2.09 Relative Strength Index (RSI) 52.28 Average Volume (20 Days) 7,717
Income Statement In the last 12 months, Spruce Biosciences had revenue of 4.91M
and earned -53.04M
in profits. Earnings per share was -96.75.
Revenue 4.91M Gross Profit 4.91M Operating Income -56.15M Net Income -53.04M EBITDA -52.68M EBIT -52.73M Earnings Per Share (EPS) -96.75
Full Income Statement Balance Sheet The company has 38.75M in cash and 2.77M in
debt, giving a net cash position of 35.99M.
Cash & Cash Equivalents 38.75M Total Debt 2.77M Net Cash 35.99M Retained Earnings -250.27M Total Assets 21.82M Working Capital 12.89M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -55.96M
and capital expenditures 0, giving a free cash flow of -55.96M.
Operating Cash Flow -55.96M Capital Expenditures n/a Free Cash Flow -55.96M FCF Per Share -104.32
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -1143.37% and -1079.94%.
Gross Margin 100% Operating Margin -1143.37% Pretax Margin -1079.94% Profit Margin -1079.94% EBITDA Margin -1072.76% EBIT Margin -1143.37% FCF Margin -1139.56%
Dividends & Yields SPRB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for SPRB is $131.25,
which is 1426.2% higher than the current price. The consensus rating is "Hold".
Price Target $131.25 Price Target Difference 1426.2% Analyst Consensus Hold Analyst Count 5
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 5, 2025. It was a
backward
split with a ratio of 1:75.
Last Split Date Aug 5, 2025 Split Type backward Split Ratio 1:75
Scores Altman Z-Score -23.27 Piotroski F-Score 1
